Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Champions Oncology (CSBR) over the last 15 years, with Q4 2025 value amounting to $8.8 million.

  • Champions Oncology's Non-Current Assets fell 2084.98% to $8.8 million in Q4 2025 from the same period last year, while for Oct 2025 it was $39.3 million, marking a year-over-year decrease of 1982.94%. This contributed to the annual value of $10.0 million for FY2025, which is 2006.72% down from last year.
  • As of Q4 2025, Champions Oncology's Non-Current Assets stood at $8.8 million, which was down 2084.98% from $9.5 million recorded in Q3 2025.
  • Over the past 5 years, Champions Oncology's Non-Current Assets peaked at $16.0 million during Q3 2022, and registered a low of $8.8 million during Q4 2025.
  • In the last 5 years, Champions Oncology's Non-Current Assets had a median value of $14.6 million in 2023 and averaged $13.4 million.
  • Per our database at Business Quant, Champions Oncology's Non-Current Assets skyrocketed by 10624.48% in 2021 and then tumbled by 2186.03% in 2024.
  • Over the past 5 years, Champions Oncology's Non-Current Assets (Quarter) stood at $15.6 million in 2021, then increased by 1.04% to $15.8 million in 2022, then fell by 9.39% to $14.3 million in 2023, then fell by 21.86% to $11.2 million in 2024, then fell by 20.85% to $8.8 million in 2025.
  • Its Non-Current Assets stands at $8.8 million for Q4 2025, versus $9.5 million for Q3 2025 and $10.0 million for Q2 2025.